MEDCO HEALTH SOLUTIONS INC Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 159 rows in 2012. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2012-04-02: Reporting owner Kornwasser Laizer; Form 4; Security Stock Option; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2012-04-02: Reporting owner Kornwasser Laizer; Form 4; Security Stock Option; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2012-04-02: Reporting owner GOLDSTEIN MICHAEL; Form 4; Security Stock Option; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
- 2012-04-02: Reporting owner GOLDSTEIN MICHAEL; Form 4; Security Stock Option; Transaction D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2012-04-02 | Kornwasser Laizer Officer (SVP, Consumer Solutions) | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −62,530 0 owned after | $63.24 exercise price | 2012-04-03 | |
| 2012-04-02 | Kornwasser Laizer Officer (SVP, Consumer Solutions) | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −14,540 0 owned after | $42.73 exercise price | 2012-04-03 | |
| 2012-04-02 | GOLDSTEIN MICHAEL Director | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,200 0 owned after | $38.87 exercise price | 2012-04-03 | |
| 2012-04-02 | GOLDSTEIN MICHAEL Director | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −7,300 0 owned after | $58.82 exercise price | 2012-04-03 | |
| 2012-04-02 | GOLDSTEIN MICHAEL Director | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,600 0 owned after | $44.38 exercise price | 2012-04-03 | |
| 2012-04-02 | GOLDSTEIN MICHAEL Director | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −7,900 0 owned after | $46.87 exercise price | 2012-04-03 | |
| 2012-04-02 | GOLDSTEIN MICHAEL Director | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,600 0 owned after | $63.41 exercise price | 2012-04-03 | |
| 2012-04-02 | EPSTEIN ROBERT S Officer (Pres, United BioSource Corp.) | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −35,220 0 owned after | $33.70 exercise price | 2012-04-03 | |
| 2012-04-02 | EPSTEIN ROBERT S Officer (Pres, United BioSource Corp.) | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −99,210 0 owned after | $39.31 exercise price | 2012-04-03 | |
| 2012-04-02 | EPSTEIN ROBERT S Officer (Pres, United BioSource Corp.) | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −64,760 0 owned after | $42.73 exercise price | 2012-04-03 | |
| 2012-04-02 | DRISCOLL JOHN PATRICK Officer (President - New Markets) | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −92,710 0 owned after | $50.35 exercise price | 2012-04-03 | |
| 2012-04-02 | DRISCOLL JOHN PATRICK Officer (President - New Markets) | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −88,880 0 owned after | $64.14 exercise price | 2012-04-03 | |
| 2012-04-02 | DRISCOLL JOHN PATRICK Officer (President - New Markets) | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −87,000 0 owned after | $62.63 exercise price | 2012-04-03 | |
| 2012-04-02 | DRISCOLL JOHN PATRICK Officer (President - New Markets) | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −33,167 0 owned after | $40.58 exercise price | 2012-04-03 | |
| 2012-04-02 | DRISCOLL JOHN PATRICK Officer (President - New Markets) | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −88,080 0 owned after | $63.24 exercise price | 2012-04-03 | |
| 2012-04-02 | DRISCOLL JOHN PATRICK Officer (President - New Markets) | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −38,800 0 owned after | $42.73 exercise price | 2012-04-03 | |
| 2012-04-02 | Daschner Mary Officer (Group President, Medicare) | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −83,600 0 owned after | $64.14 exercise price | 2012-04-03 | |
| 2012-04-02 | Daschner Mary Officer (Group President, Medicare) | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −78,300 0 owned after | $62.63 exercise price | 2012-04-03 | |
| 2012-04-02 | Daschner Mary Officer (Group President, Medicare) | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −68,885 0 owned after | $40.58 exercise price | 2012-04-03 | |
| 2012-04-02 | Daschner Mary Officer (Group President, Medicare) | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −62,530 0 owned after | $63.24 exercise price | 2012-04-03 | |
| 2012-04-02 | Daschner Mary Officer (Group President, Medicare) | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −14,680 0 owned after | $33.70 exercise price | 2012-04-03 | |
| 2012-04-02 | Daschner Mary Officer (Group President, Medicare) | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −7,680 0 owned after | $28.17 exercise price | 2012-04-03 | |
| 2012-04-02 | CASSIS JOHN L Director | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,200 0 owned after | $38.87 exercise price | 2012-04-03 | |
| 2012-04-02 | CASSIS JOHN L Director | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −7,300 0 owned after | $58.82 exercise price | 2012-04-03 | |
| 2012-04-02 | CASSIS JOHN L Director | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,600 0 owned after | $44.38 exercise price | 2012-04-03 | |
| 2012-04-02 | CASSIS JOHN L Director | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −7,900 0 owned after | $46.87 exercise price | 2012-04-03 | |
| 2012-04-02 | CASSIS JOHN L Director | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,600 0 owned after | $63.41 exercise price | 2012-04-03 | |
| 2012-04-02 | Cappucci Gabriel R. Officer (SVP, Contr & Chief Acct. Off.) | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −15,200 0 owned after | $50.35 exercise price | 2012-04-03 | |
| 2012-04-02 | Cappucci Gabriel R. Officer (SVP, Contr & Chief Acct. Off.) | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −7,550 0 owned after | $33.70 exercise price | 2012-04-03 | |
| 2012-04-02 | Cappucci Gabriel R. Officer (SVP, Contr & Chief Acct. Off.) | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −7,200 0 owned after | $28.17 exercise price | 2012-04-03 | |
| 2012-04-02 | Cappucci Gabriel R. Officer (SVP, Contr & Chief Acct. Off.) | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −9,230 0 owned after | $22.10 exercise price | 2012-04-03 | |
| 2012-04-02 | Cappucci Gabriel R. Officer (SVP, Contr & Chief Acct. Off.) | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −25,080 0 owned after | $64.14 exercise price | 2012-04-03 | |
| 2012-04-02 | Cappucci Gabriel R. Officer (SVP, Contr & Chief Acct. Off.) | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −23,580 0 owned after | $62.63 exercise price | 2012-04-03 | |
| 2012-04-02 | Cappucci Gabriel R. Officer (SVP, Contr & Chief Acct. Off.) | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −9,000 0 owned after | $16.26 exercise price | 2012-04-03 | |
| 2012-04-02 | Cappucci Gabriel R. Officer (SVP, Contr & Chief Acct. Off.) | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −27,250 0 owned after | $40.58 exercise price | 2012-04-03 | |
| 2012-04-02 | Cappucci Gabriel R. Officer (SVP, Contr & Chief Acct. Off.) | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −24,130 0 owned after | $63.24 exercise price | 2012-04-03 | |
| 2012-04-02 | BARKER HOWARD W JR Director | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,200 0 owned after | $38.87 exercise price | 2012-04-03 | |
| 2012-04-02 | BARKER HOWARD W JR Director | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,000 0 owned after | $26.02 exercise price | 2012-04-03 | |
| 2012-04-02 | BARKER HOWARD W JR Director | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −7,300 0 owned after | $58.82 exercise price | 2012-04-03 | |
| 2012-04-02 | BARKER HOWARD W JR Director | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −8,600 0 owned after | $44.38 exercise price | 2012-04-03 | |
| 2012-04-02 | BARKER HOWARD W JR Director | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −7,900 0 owned after | $46.87 exercise price | 2012-04-03 | |
| 2012-04-02 | BARKER HOWARD W JR Director | 4 | Stock Option Derivative · Direct | D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | −6,600 0 owned after | $63.41 exercise price | 2012-04-03 | |
| 2012-02-27 | CASSIS JOHN L Director | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −16,000 0 owned after | $26.02 exercise price | 2012-02-28 | |
| 2012-02-24 | Cappucci Gabriel R. Officer (SVP, Contr & Chief Acct. Off.) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,080 25,080 owned after | $64.14 exercise price | 2012-02-28 | |
| 2012-02-24 | KLEPPER KENNETH O Officer (President-Chief Oper. Officer) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +176,000 176,000 owned after | $64.14 exercise price | 2012-02-28 | |
| 2012-02-24 | Moriarty Thomas M Officer (Gen'l Counsel & Secretary, SVP) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +105,600 105,600 owned after | $64.14 exercise price | 2012-02-28 | |
| 2012-02-24 | Daschner Mary Officer (Group President, Medicare) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +83,600 83,600 owned after | $64.14 exercise price | 2012-02-28 | |
| 2012-02-24 | SHEEHY FRANK J Officer (Pres. Accredo Health Group, I) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +72,160 72,160 owned after | $64.14 exercise price | 2012-02-28 | |
| 2012-02-24 | GRIFFIN BRIAN T Officer (President, International) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +94,160 94,160 owned after | $64.14 exercise price | 2012-02-28 | |
| 2012-02-24 | Kornwasser Laizer Officer (SVP, Consumer Solutions) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +83,600 83,600 owned after | $64.14 exercise price | 2012-02-28 | |
| 2012-02-24 | PRINCIVALLE KARIN Officer (SVP, Human Resources) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +48,840 48,840 owned after | $64.14 exercise price | 2012-02-28 | |
| 2012-02-24 | Stettin Glen D. Officer (Chief Medical Officer) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +48,400 48,400 owned after | $64.14 exercise price | 2012-02-28 | |
| 2012-02-24 | SMITH JACK ALLEN Officer (SVP, Chief Marketing Officer) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +51,920 51,920 owned after | $64.14 exercise price | 2012-02-28 | |
| 2012-02-24 | SNOW DAVID B JR Director, Officer (Chairman and CEO) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +581,465 581,465 owned after | $64.14 exercise price | 2012-02-28 | |
| 2012-02-24 | RUBINO RICHARD J Officer (SVP, Finance & CFO) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +117,920 117,920 owned after | $64.14 exercise price | 2012-02-28 | |
| 2012-02-24 | WENTWORTH TIMOTHY C Officer (Group Pres, Employer Accounts) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +95,920 95,920 owned after | $64.14 exercise price | 2012-02-28 | |
| 2012-02-24 | TAYLOR GLENN C Officer (Group President, Health Plans) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +94,160 94,160 owned after | $64.14 exercise price | 2012-02-28 | |
| 2012-02-24 | DRISCOLL JOHN PATRICK Officer (President - New Markets) | 4 | Stock Option Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +88,880 88,880 owned after | $64.14 exercise price | 2012-02-28 | |
| 2012-01-06 | WILSON BLENDA J Director | 4 | Stock Option Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −3,500 5,250 owned after | $26.02 exercise price | 2012-01-10 |